Technolas TENEO 317 Model 2 Excimer Laser
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Technolas TENEO 317 Model 2 Excimer Laser, covering 2024-06-14 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism [NA]